|
Prior to joining Immune Control, Mr. Sandquist held a number of senior leadership roles at Merck where he commercialized and launched products in the United States and Europe. As a Vice President at Merck, Eric championed a global strategic initiative to improve the efficiency and effectiveness of product commercialization. In the role of Managing Director at Merck, Eric led a European subsidiary competing in nine therapeutic areas to achieve greater profitability, operational efficiency and market access. Eric also led the commercial development and launch of new products within Merck at the global headquarters and subsidiary levels. For example, Eric was responsible for the global launch of Maxalt ® that has yielded $2 billion in cumulative sales. Eric earned a BA in history with honors from the University of Massachusetts, Amherst, and an MBA from Harvard Business School. | 